Health officials have updated national guidance for parents regarding Meningitis B (MenB) protection, following a series of regional outbreaks in the South East of England earlier this year. The UK Health Security Agency (UKHSA) refreshed the formal advice on 30 September 2026 to ensure families are aware of both the routine infant schedule and a time-limited catch-up programme for young adults.
The move follows reports of meningococcal disease in Kent and Reading during 2026, which prompted a region-wide push for vaccination awareness across the South East, including West Sussex. MenB remains the leading cause of bacterial meningitis in the UK, a serious infection that can cause brain damage, amputations, and in some cases, death.
Routine Vaccination for Babies
The routine MenB vaccination programme, first introduced in 2015, has led to a 75% reduction in disease within vaccinated age groups. To maintain this protection, the NHS follows a specific three-dose schedule for infants:
- 8 weeks: First dose
- 12 weeks: Second dose
- 1 year: Final booster
Health officials have issued a specific recommendation for parents of infants receiving these jabs. A 2.5ml dose of liquid paracetamol should be administered to babies after their 8-week and 12-week vaccinations. This is to reduce the risk of high fever, which is a common side effect of the MenB vaccine in very young children.
For children who have missed their scheduled appointments, a catch-up course is available through GP surgeries until the child reaches their second birthday. You can find more information on the NHS guide to MenB vaccinations.
The 2026 Student Catch-Up Window
In addition to infant care, a one-off vaccination programme is currently active for young people in 2026. This is aimed at protecting those at higher risk of contracting the disease as they enter communal living environments, such as university halls or residential colleges.
Those eligible for this specific time-limited offer include:
- Young people born between 1 September 2007 and 31 August 2008.
- Students under the age of 25 who are starting university or residential further education for the first time this autumn.
Crucially, first doses for this student catch-up programme must be administered by 31 December 2026. Parents and students are encouraged to distinguish this from the MenACWY vaccine, which is typically given to teenagers in Year 9 (around age 14). The MenB jab is a separate protection against a different strain of the bacteria.
Recognising the Symptoms
While vaccinations provide significant protection, health officials advise parents to remain vigilant for symptoms of meningococcal disease and septicaemia. The disease can progress very quickly, and early medical intervention is vital.
Key signs to watch for include a high fever accompanied by cold hands and feet, a stiff neck, severe drowsiness, and sensitivity to bright lights. A hallmark symptom is a purple or red rash that does not fade when a glass is pressed firmly against it (the ‘glass test’). If a child or young person appears seriously unwell, medical advice should be sought immediately, even if they have been previously vaccinated.
